Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Aptinyx Stock Soared on Friday

TheMotleyFool

0 0

Shares of Aptinyx (NASDAQ: APTX), a clinical-stage biotech focused on the brain and nervous system, rose about 27% on Friday.

The double-digit jump appears to be linked to the filing of an SEC document that shows that Adams Street Partners -- an investment management company with $40 billion in assets -- has acquired more than 5 million shares of Aptinyx's stock. That position represents more than 11% of shares outstanding.

Image source: Getty Images.

Source Fool.com

Like: 0

APTX

Share